نتایج جستجو برای: lam

تعداد نتایج: 6996  

Journal: :Journal of hepatology 2012
Massimo Fasano Pietro Lampertico Alfredo Marzano Vito Di Marco Grazia Anna Niro Giuseppina Brancaccio Andrea Marengo Gaetano Scotto Maurizia Rossana Brunetto Giovanni Battista Gaeta Mario Rizzetto Gioacchino Angarano Teresa Santantonio

BACKGROUND & AIMS In long-term responder patients, it is unclear whether lamivudine (LAM) monotherapy should be continued or switched to a high-genetic-barrier analogue. This study aims at assessing LAM efficacy over a 5-year period and the residual risk of drug resistance. The rate of HBsAg clearance and LAM long-term safety profile were also evaluated. METHODS One hundred and ninety-one pat...

2018
Heon Ju Lee Sang Jin Kim Young Oh Kweon Soo Young Park Jeong Heo Hyun Young Woo Jae Seok Hwang Woo Jin Chung Chang Hyeong Lee Byung Seok Kim Jeong Ill Suh Won Young Tak Byoung Kuk Jang

BACKGROUND The efficacy of switching to tenofovir disoproxil fumarate (TDF) monotherapy from lamivudine (LAM) plus adefovir dipivoxil (ADV) combination therapy (stable switching) in patients with LAM-resistant chronic hepatitis B (CHB) and undetectable hepatitis B virus (HBV) DNA is not clear. METHODS In this non-inferiority trial, patients with LAM-resistant CHB and undetectable serum HBV DN...

2013
Aikaterini Patsatsi Aikaterini Kyriakou George Chaidemenos Dimitrios Sotiriadis

Linear atrophoderma of Moulin (LAM) is a rare dermatosis in childhood and early adolescence. The exact etiology of LAM is still obscure. Several treatment modalities were reported but none was consistently successful. We report a case of LAM in which a favorable outcome was obtained with topical calcipotriol. The relevant literature is also reviewed.

2014
Chenggang Li Po-Shun Lee Yang Sun Xiaoxiao Gu Erik Zhang Yanan Guo Chin-Lee Wu Neil Auricchio Carmen Priolo Jing Li Alfredo Csibi Andrey Parkhitko Tasha Morrison Anna Planaguma Shamsah Kazani Elliot Israel Kai-Feng Xu Elizabeth Petri Henske John Blenis Bruce D. Levy David Kwiatkowski Jane J. Yu

Lymphangioleiomyomatosis (LAM) is a progressive neoplastic disorder that leads to lung destruction and respiratory failure primarily in women. LAM is typically caused by tuberous sclerosis complex 2 (TSC2) mutations resulting in mTORC1 activation in proliferative smooth muscle-like cells in the lung. The female predominance of LAM suggests that estradiol contributes to disease development. Meta...

2015
Leslie Chávez-Galán Ranferi Ocaña-Guzmán Luis Torre-Bouscoulet Carolina García-de-Alba Isabel Sada-Ovalle

Lipoarabinomannan (LAM) is a lipid virulence factor secreted by Mycobacterium tuberculosis (Mtb), the etiologic agent of tuberculosis. LAM can be measured in the urine or serum of tuberculosis patients (TB-patients). Circulating monocytes are the precursor cells of alveolar macrophages and might be exposed to LAM in patients with active TB. We speculated that exposing monocytes to LAM could pro...

Journal: :Journal of acquired immune deficiency syndromes 2009
Maunank Shah Ebrahim Variava Charles B Holmes Alison Coppin Jonathan E Golub Jeremy McCallum Michelle Wong Binu Luke Desmond J Martin Richard E Chaisson Susan E Dorman Neil A Martinson

BACKGROUND Effective tuberculosis (TB) control in HIV-prevalent settings is hindered by absence of accurate, rapid TB diagnostic tests. We evaluated the accuracy of a urine lipoarabinomannan (LAM) test for TB diagnosis in South Africa. METHODS Hospitalized adults with signs and/or symptoms of active TB were enrolled. Sputum smear microscopy and mycobacterial culture, mycobacterial blood cultu...

Journal: :Journal of medical genetics 2000
A Astrinidis L Khare T Carsillo T Smolarek K S Au H Northrup E P Henske

Pulmonary lymphangioleiomyomatosis (LAM) is a rare disorder limited almost exclusively to women of reproductive age. LAM affects about 5% of women with tuberous sclerosis complex (TSC). LAM also occurs in women who do not have TSC (sporadic LAM). TSC is a tumour suppressor gene syndrome characterised by seizures, mental retardation, and tumours in the brain, heart, and kidney. Angiomyolipomas, ...

Journal: :Contraception 1997
M H Labbok V Hight-Laukaran A E Peterson V Fletcher H von Hertzen P F Van Look

A multicenter study of the Lactational Amenorrhea Method (LAM) was carried out to test the acceptability and efficacy of the method. Additionally, the data are used to test new constructs for improvement of method criteria. A protocol was designed at the Institute for Reproductive Health (IRH), Department of Obstetrics and Gynecology, Georgetown University Medical Center, a World Health Organiz...

2014
Alexey Tyryshkin Abhisek Bhattacharya Tony Eissa

Lymphangioleiomyomatosis (LAM) is a progressive cystic lung disease affecting some women with tuberous sclerosis complex (TSC). Sporadic LAM can develop in women without TSC, owing to somatic mutations in the TSC2 gene. Accumulating evidence supports the view of LAM as a low-grade, destructive, metastasizing neoplasm. The mechanisms underlying the metastatic capability of LAM cells remain poorl...

Journal: :Antiviral therapy 2012
Chien-Hung Chen Jing-Houng Wang Sheng-Nan Lu Tsung-Hui Hu Chao-Hung Hung Min-Hui Chang Chi-Sin Changchien Chuan-Mo Lee

BACKGROUND Here, we investigated the treatment response and evolution of HBV resistance during lamivudine (LAM) plus adefovir (ADV) and entecavir (ETV) monotherapy in patients with ADV-resistant mutants. METHODS Of the 53 patients with ADV-resistant mutants, 25 received combined LAM plus ADV therapy (LAM+ADV group) and 28 received ETV monotherapy (ETV group) for at least 12 months (median 24 ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید